Co-pay accumulator adjustment programs are meant to ensure that individuals are responsible for the full amount of their insurance deductible, which should help promote healthcare consumerism, according to Bruce Sherman, MD, chief medical officer of the National Alliance of Healthcare Purchaser Coalitions.
Co-pay accumulator adjustment programs are meant to ensure that individuals are responsible for the full amount of their insurance deductible, which should help promote healthcare consumerism, according to Bruce Sherman, MD, chief medical officer of the National Alliance of Healthcare Purchaser Coalitions.
Transcript
What are co-pay accumulator programs and what purpose are they supposed to serve?
The intent of co-pay accumulator programs is to ensure that individuals who elect to enroll in a high-deductible or consumer-directed health plan fulfill the obligation of their enrollment in that plan to pay for the deductible in its full amount before the health plan or the benefit plan kicks in to support their healthcare needs.
The co-pay accumulator adjustment programs serve to prevent individuals from having any funds credited toward their deductible that come from an outside entity, such as a pharmaceutical manufacturer, that prior to about 2017 were being counted toward the patient contribution. Now with the implementation of co-pay accumulator adjustment programs, the [pharmacy benefit managers] are able to identify the source of funds, whether they are coming from the patients, whether they’re coming from a third-party source, and attribute those to the deductible or not based on the particular plan design.
So the accumulator program specifically is intended to prevent any contribution from outside of the patient from being credited toward the individual’s deductible, and that, at least theoretically, should help promote healthcare consumerism by ensuring that patients are responsible for that full amount of the deductible as the plan depicts.
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen